Form 4/A for AQST Aquestive Therapeutics, Inc.
Accepted 2024-10-02 00:00:00 ET · period of report 2024-03-09 · accession 0001214659-24-017011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-10-02 | 2024-03-09 | AQST | Schobel Alexander Mark | Chief Innovation, Tech Off | F - Tax | $4.88 | -9,645 | 980.7K | -1.0% | -$47.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-09 | F | D | 9,645 | $4.88 | 980,726 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 . |